Pharma Industry News
A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.
Why Royalty Pharma Investors Could Be the Quiet Winners From Revolution Medicines' Groundbreaking Pancreatic Cancer Drug
Revolution Medicines (RVMD +8.23%) invested significant time, energy, and money to advance its pancreatic cancer drug daraxonrasib through the FDA approval process. The payoff could be huge, with Royalty Pharma (RPRX -0.40%) estimating that the…
Diwali Muhurat Trading 2026: 3 Stocks With 25% Potential Upside
Samvat 2083: Muhurat trading should be approached with a quality-first investment strategy. Summary is AI-generated, newsroom-reviewed Aurobindo Pharma, Balkrishna Industries, and Mahindra & Mahindra are top Diwali Muhurat trading picks Mahindra &…
Ascendis Pharma A/S (NASDAQ:ASND) Upgraded at Wall Street Zen
Ascendis Pharma A/S (NASDAQ:ASND - Get Free Report) was upgraded by equities researchers at Wall Street Zen from a 'hold' rating to a 'buy' rating in a note issued to investors on Sunday, Wall Street Zen reports. Can BioMarin Stock Live Up to Wall…
BridgeBio Pharma, Inc. $BBIO Stake Increased by Candriam S.C.A.
Candriam S.C.A. increased its stake in shares of BridgeBio Pharma, Inc. (NASDAQ:BBIO - Free Report) by 133.9% during the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The…
French director Marine Atlan receives Reflet d'Or at GIFF
WHO candidate Maria Neira: ‘We need to rebuild credibility and trust' Read more: WHO candidate Maria Neira: ‘We need to rebuild credibility and trust' China blocks SoftBank's $5.4bn takeover of ABB's robotics division Read more: China…
Rakuten Investment Management Inc. Purchases 26,660 Shares of Royalty Pharma PLC $RPRX
Rakuten Investment Management Inc. acquired a new stake in shares of Royalty Pharma PLC (NASDAQ:RPRX - Free Report) during the third quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional…
Indian Stock Market: Sensex, Nifty Start Samvat 2083 Bullish in Muhurat Trading
Indian benchmark indices Sensex and Nifty commenced the special Muhurat trading session for Samvat 2083 on a strong bullish note, reflecting investor optimism for the new Hindu calendar year. Benchmark indices Sensex and Nifty started the special…
7,274 Shares of Ascendis Pharma A/S $ASND Bought by Mirae Asset Global Investments Co. Ltd.
Mirae Asset Global Investments Co. Ltd. bought a new position in shares of Ascendis Pharma A/S (NASDAQ:ASND - Free Report) during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund…
Mirae Asset Global Investments Co. Ltd. Buys 20,183 Shares of BridgeBio Pharma, Inc. $BBIO
Mirae Asset Global Investments Co. Ltd. bought a new stake in BridgeBio Pharma, Inc. (NASDAQ:BBIO - Free Report) during the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission…
Indian Stock Markets See Marginal Dip in Special Muhurat Trading Session
Indian stock markets concluded their special Diwali Muhurat trading session with a marginal dip, as benchmark indices Sensex and Nifty ended lower, breaking a robust seven-day rally amidst investor profit-taking. Benchmark indices Sensex and Nifty…
Stock markets begin Samvat 2083 on a firm note in special Muhurat trading
Benchmark indices Sensex and Nifty started the special Muhurat trading session on a bullish note on Sunday (November 8, 2026), supported by buying in blue-chips such as Sun Pharma, Tata Steel and ICICI Bank. Continuing the prevailing bullish trend…
GLP-1 Series #17: I gave Big Pharma an F this week...
Earlier this week, I got to join a major agency for a client-facing seminar on the future of influencers and content creators. They asked the questions you'd expect. What makes a brand campaign work? How do I see things as both an influencer and a…
Sensex, Nifty end lower in Diwali muhurat trading
Benchmark indices Sensex and Nifty ended marginally lower in the special Diwali Muhurat trading session on Sunday amid profit-taking by investors after a seven-day rally. After starting the special trading session to mark the beginning of Hindu…
COP31: WHO Dir-Gen Tedros: 'The climate crisis is fueling outbreaks, driving higher rates of heart & lung disease, cancer & asthma' - 'Health is the most compelling reason for climate action'
The WHO Director-General is blaming climate change for the increase in heart and lung disease and cancers. No wonder the WHO continues to lose its credibility. https://t.co/iKIrqR0imH — Dr. Kat Lindley (@DrKatLindley) November 8, 2026 Dr…
Novo Nordisk's Wegovy Pill Has Topped 5 Million Prescriptions. Is the Stock a Buy Now?
Novo Nordisk (NVO +0.03%) now goes by the name Novo, a move intended to highlight the company's changed business focus. Nothing really changed about the company, per se, but as you assess the success of the drugmaker's Wegovy GLP-1 weight-loss…
Receive a Daily briefing on Pharma Industry News
Get Started